Perrigo is recalling approximately 7.7 million units of Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation) because the inhalers may fail to dispense medication as intended. This defect is caused by a sustained trend of delivery system failures where the device does not release the life-saving asthma medication when the consumer presses the canister. These inhalers were manufactured by Catalent Pharma Solutions and distributed nationwide under the Perrigo label with NDC 45802-088-01.
If the delivery system fails during a sudden asthma attack or respiratory distress, the patient will not receive the necessary medication to open their airways. This failure to dispense can lead to life-threatening respiratory symptoms or a lack of relief during an emergency medical event.
Pharmacy-level refund and medical guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.